SYGNIS Pharma AG Reports Financial Results for Third Quarter

February 18, 2008 |

1 min read

Heidelberg, February 12th 2008 – SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports its financial results for the period ended 31 December 2007.

Earnings Europe

MORE ON THIS TOPIC

Target concept vector illustration. Business goal, marketing strategy, digital aim, bullseye accuracy, cyber challenge, innovation target, focus objective, dart board, internet market.

Phase 3

Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition

August 13, 2026

·

3 min read

·

Gabrielle Masson

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

MindMaze trims Relief staff, Aardvark cuts workforce amid Prader-Willi troubles

August 13, 2026

·

83 min read

·

BioSpace Editorial Staff

Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties

Rare diseases

Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M

August 13, 2026

·

2 min read

·

Tristan Manalac

Business bankruptcy assistance concept. businessman on a paper boat and rescues a drowning man vector

Bankruptcy

Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale

August 13, 2026

·

2 min read

·

Tristan Manalac